JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 14, 2006; DOI: 10.1124/jpet.106.101279


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.101279v1
317/3/1330    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubinion, J. H.
Right arrow Articles by Jackson, E. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dubinion, J. H.
Right arrow Articles by Jackson, E. K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure


Received for publication January 13, 2006.
Revised March 10, 2006.
Accepted for publication March 13, 2006.

Role Of Renal Sympathetic Nerves In Regulating Renovascular Responses To Angiotensin II in SHR

John H. Dubinion 1, Zaichuan Mi 1, Edwin K. Jackson 1*

1 University of Pittsburgh

* Address correspondence to: E-mail: edj{at}pitt.edu

Abstract

The purpose of this study was to test the hypothesis that renal sympathetic nerves modulate angiotensin II-induced renal vasoconstriction in kidneys from genetically hypertensive rats via Y1 receptors activating the Gi pathway. In isolated, perfused kidneys from spontaneously hypertensive rats, the naturally-occuring renal sympathetic co-transmitter neuropeptide Y at 6 nmoles/L enhanced angiotensin II (0.3 nmoles/L)-induced changes in perfusion pressure by 47 ± 7 mm Hg, and this effect was inhibited by BIBP3226 (a selective Y1-receptor antagonist, 1 µmole/L). We next examined whether periarterial nerve stimulation (5 Hz) enhances renal vascular responses to a physiological level of angiotensin II (100 pmoles/L). Kidneys were pretreated with prazosin (a selective {alpha}1-adrenoceptor antagonist) to block nerve stimulation-induced changes in perfusion pressure. In kidneys from spontaneously hypertensive rats, but not normotensive rats, periarterial nerve stimulation significantly augmented angiotensin II-induced changes in perfusion pressure (177 ± 26% of response in absence of stimulation). BIBP3226, but not rauwolscine (a selective {alpha}2-adrenoceptor antagonist), abrogated periarterial nerve stimulation-induced enhancement of angiotensin II-mediated renal vasoconstriction. Pretreatment of hypertensive animals with pertussis toxin three days prior to kidney perfusion significantly (P<0.000001) decreased mean blood pressure (203 ± 2 versus 145 ± 6 mm Hg in non-pretreated versus pertussis toxin-pretreated SHR) and abolished periarterial nerve stimulation-induced enhancement of angiotensin II-mediated renal vasoconstriction. We conclude that in spontaneously hypertension rats, but not normotensive rats, sympathetic nerve stimulation enhances renal vascular responses to physiological levels of angiotensin II via a mechanism mainly involving Y1 receptors coupled to Gi proteins.


Key words: angiotensin II, neuropeptide Y, perfused rat kidney, renal vascular resistance, spontaneously hypertensive rat, sympathetic nervous system


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Byku, H. Macarthur, and T. C. Westfall
Nerve stimulation induced overflow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2188 - H2197.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. K. Jackson and Z. Mi
Sitagliptin Augments Sympathetic Enhancement of the Renovascular Effects of Angiotensin II in Genetic Hypertension
Hypertension, June 1, 2008; 51(6): 1637 - 1642.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. G. R. De Mey, R. Megens, and G. E. Fazzi
Functional Antagonism between Endogenous Neuropeptide Y and Calcitonin Gene-Related Peptide in Mesenteric Resistance Arteries
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 930 - 937.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. K. Jackson, M. Zhang, W. Liu, and Z. Mi
Inhibition of Renal Dipeptidyl Peptidase IV Enhances Peptide YY1 36-Induced Potentiation of Angiotensin II-Mediated Renal Vasoconstriction in Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 431 - 437.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. H. Beierwaltes
Induction of Heme Oxygenase: Can It Really Reverse Hypertension?
Hypertension, October 1, 2006; 48(4): 555 - 557.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.